Abstract View

Author(s): Deepa Gavit*1, Dhara Patel2, Girishna Patel3, Tejas Patel4, Dhananjay Meshram5

Email(s): 1gavitdeepa05@gmail.com

Address:

    Department of Pharmaceutical Quality Assurance, pioneer pharmacy College Nr.Ajwa Crossing sayajipura, vadodara-390019,Gujrat, India

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5621  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The pharmaceutical manufacturing industry is rapidly moving toward digital transformation and advanced quality management systems to improve product quality, manufacturing efficiency, and regulatory compliance. Data-driven quality improvement has become an important approach for identifying process variability, reducing human errors, minimizing deviations, and improving overall manufacturing performance. Modern pharmaceutical industries generate large amounts of production and quality-related data through manufacturing execution systems (MES), laboratory information management systems (LIMS), enterprise resource planning (ERP), process analytical technology (PAT), and automated manufacturing equipment. The proper analysis and utilization of this data help industries in making better decisions, improving process control, and maintaining product consistency. Advanced technologies such as artificial intelligence (AI), machine learning (ML), big data analytics, cloud computing, and Industry 4.0 tools are increasingly being implemented in pharmaceutical manufacturing environments. The regulatory authorities it is including the USFDA, WHO, and ICH emphasize data integrity, quality risk management (QRM) and continuous improvement as essential elements of the modern pharmaceutical quality systems. This review article discusses the concept of data-driven quality improvement in pharmaceutical manufacturing environments, major data sources, digital technologies, statistical tools, regulatory perspectives, benefits, challenges, and future opportunities.

Cite this article:
Deepa Gavit, Dhara Patel, Girishna Patel, Tejas Patel, Dhananjay Meshram. Data-Driven Quality Improvement in Pharmaceutical Manufacturing Environment. IJRPAS, June 2026; 5(6): 277-304DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5621


References not available.

Related Images:



Recent Images



Impaired Glucose Homeostasis During Clozapine Therapy in A Schizophrenic Patient: A Case Report
Development and Validation of an Eco-Friendly RP-HPLC Method for the Quantitative Estimation of Desidustat in Human Plasma
Personalized Pharmacotherapy in Obesity: Current Challenges, Emerging Therapeutic Algorithms, and Future Directions
Petrological Study on Sunstone: An Interdisciplinary Approach to Evaluate the Effect of Shodhana by Petrographic Thin Section Analysis
Gut Microbiota in Human Health And Disease: A Review of Therapeutic Opportunities.
Development and evaluation of Metformin Hydrochloride floating tablets using natural polymers with drug-polymer compatibility study by FTIR and analysis by UV spectrophotometer
Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method

Tags